안녕하신가 LookChem.com 로그인|무료 참가
  • or

네 라티 닙메이커 CAS 레지스트리 번호698387-09-6공급업체 | LookChem

네 라티 닙

기본 정보 Edit
  • 표준명:네 라티 닙
  • CAS 레지스트리 번호:698387-09-6
  • 분자식:C30H29ClN6O3
  • 분자 무게:557.052
  • HS 코드:29334900
  • Mol 파일:698387-09-6.mol
네 라티 닙

동의어: neratinibNeratinib(2E)-N-[4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)-2-butenamide(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide(E)-N-[4-((3-chloro-4-((pyridine-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide(E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethyloxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide(E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide

관련 CAS 번호: 6000-00-6 6000-08-4 60000-87-5 60002-09-7 60003-66-9 60-00-4 6000-40-4 6000-41-5 60004-36-6 60004-37-7

표준명의 마케팅 및 가격
제조업체 및 유통업체:
  • 제조/브랜드
  • 화학물질 및 원자재
  • 포장
  • 가격
  • TRC
  • Neratinib
  • 25mg
  • $ 280.00
  • TRC
  • Neratinib
  • 100mg
  • $ 890.00
  • Matrix Scientific
  • (E)-N-(4-(3-Chloro-4-(pyridin-2-yLmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide 95%
  • 5g
  • $ 5273.00
  • Matrix Scientific
  • (E)-N-(4-(3-Chloro-4-(pyridin-2-yLmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide 95%
  • 1g
  • $ 1758.00
  • DC Chemicals
  • Neratinib(HKI-272) >99%
  • 100 mg
  • $ 200.00
  • DC Chemicals
  • Neratinib(HKI-272) >99%
  • 1 g
  • $ 800.00
  • DC Chemicals
  • Neratinib(HKI-272) >99%
  • 250 mg
  • $ 400.00
  • Crysdot
  • Neratinib 98+%
  • 250mg
  • $ 275.00
  • Chemtos
  • Neratinibd5
  • 25 mg
  • $ 1990.00
  • ChemScene
  • Neratinib 99.04%
  • 250mg
  • $ 160.00
총 157 개 원재료 공급업체
표준명의 화학적 성질 Edit
물리적 데이터:
안전정보:
  • 픽토그램:
  • 위험 코드:
  • 진술:
  • 안전 선언문:
사용:
  • 소개 및 적용: Neratinib (HKI-272) is an oral, irreversible dual inhibitor of EGFR and HER2, which are receptors known to play a central role in cell proliferation and cancer development. It is highly selective and has potent antitumor activity against breast and non-small cell lung cancer. Neratinib has an IC50 of 59 nM for HER2 kinase and 92 nM for EGFR, and shows greater selectivity over other kinases. As an irreversible inhibitor, it may overcome resistance to reversible inhibitors like gefitinib. Neratinib has been evaluated in clinical trials for cancers with HER2 overexpression or activating mutations.
가격에 대한 견적 요청 게시